In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4.
Publication
, Journal Article
Romiti, GF; Talerico, G
Published in: Ann Intern Med
November 2024
Lopes RD, Granger CB, Wojdyla DM, et al. Apixaban vs aspirin according to CHA2DS2-VASc score in subclinical atrial fibrillation: insights from ARTESiA. J Am Coll Cardiol. 2024;84:354-364. 39019530.
Duke Scholars
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
November 2024
Volume
177
Issue
11
Start / End Page
JC125
Location
United States
Related Subject Headings
- Stroke
- Risk Assessment
- Pyridones
- Pyrazoles
- Platelet Aggregation Inhibitors
- Male
- Humans
- General & Internal Medicine
- Female
- Factor Xa Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
Romiti, G. F., & Talerico, G. (2024). In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4. Ann Intern Med, 177(11), JC125. https://doi.org/10.7326/ANNALS-24-02625-JC
Romiti, Giulio Francesco, and Giovanni Talerico. “In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4.” Ann Intern Med 177, no. 11 (November 2024): JC125. https://doi.org/10.7326/ANNALS-24-02625-JC.
Romiti GF, Talerico G. In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4. Ann Intern Med. 2024 Nov;177(11):JC125.
Romiti, Giulio Francesco, and Giovanni Talerico. “In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4.” Ann Intern Med, vol. 177, no. 11, Nov. 2024, p. JC125. Pubmed, doi:10.7326/ANNALS-24-02625-JC.
Romiti GF, Talerico G. In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4. Ann Intern Med. 2024 Nov;177(11):JC125.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
November 2024
Volume
177
Issue
11
Start / End Page
JC125
Location
United States
Related Subject Headings
- Stroke
- Risk Assessment
- Pyridones
- Pyrazoles
- Platelet Aggregation Inhibitors
- Male
- Humans
- General & Internal Medicine
- Female
- Factor Xa Inhibitors